Literature DB >> 30530521

High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.

Ying Dong1, Xin Wang1, Linfeng Zhang1, Zuo Chen1, Congyi Zheng1, Jiali Wang1, Yuting Kang1, Lan Shao1, Ye Tian1, Zengwu Wang1.   

Abstract

BACKGROUND: This study aimed to assess the association of high sensitivity C-reactive protein (hs-CRP) with cardiovascular disease (CVD) in middle-aged Chinese population.
METHODS: The baseline was collected 2009-2010, and follow-up was conducted in 2016-2017. Data of hs-CRP were from baseline examination and re-examination in 2016-2017 using transmission turbidimetry with a measurement range of 0-42 000. The primary outcome was CVD including coronary heart disease events and stroke events.
RESULTS: Among 8688 participants free from CVD (at baseline, mean age, 50.1 years, 3897 were males), there were 189 CVD events, occurred during a median follow-up of 6.34 years (54 685 person-years at risk). From the Kaplan-Meier curve, we found that there was a progressive increase in CVD event rates by hs-CRP tertiles (log-rank test, p<0.001). Baseline hs-CRP was linearly associated with CVD (p for trend=0.015) even after adjusting for known CVD risk factors. Furthermore, the net reclassification improvement when hs-CRP was added to a model based on traditional factors was 7.85% for CVD (p=0.003). In addition, the correlation between change of hs-CRP and CVD was conducted in a subgroup (n=4778). However, we did not find the correlation between hs-CRP change and CVD (correlation coefficient: -0.003, p=0.846).
CONCLUSIONS: In the middle-aged Chinese population, hs-CRP was associated with increased risk of developing CVD. Although there was no correlation between hs-CRP change and CVD, the level of hs-CRP was higher at follow-up than baseline even among those with CVD. More attention should be given to those with higher level of hs-CRP for CVD prevention. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiovascular disease; cohort studies; epidemiology

Mesh:

Substances:

Year:  2018        PMID: 30530521     DOI: 10.1136/jech-2018-211433

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  11 in total

Review 1.  The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Seyyed Mostafa Arabi; Mahla Chambari; Mahsa Malek-Ahmadi; Leila Sadat Bahrami; Vahid Hadi; Manfredi Rizzo; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2022-08-21       Impact factor: 5.093

2.  Approach to risk stratification of atherosclerotic cardiovascular disease: Use of biomarkers and imaging in a Canadian context.

Authors:  Daniel Esau; Beth L Abramson
Journal:  Can Fam Physician       Date:  2022-09       Impact factor: 3.025

3. 

Authors:  Daniel Esau; Beth L Abramson
Journal:  Can Fam Physician       Date:  2022-09       Impact factor: 3.025

Review 4.  Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies.

Authors:  Xingjin Yang; Dongdong Zhang; Yang Zhao; Dechen Liu; Quanman Li; Chunmei Guo; Gang Tian; Minghui Han; Ranran Qie; Shengbing Huang; Qionggui Zhou; Yang Zhao; Yifei Feng; Xiaoyan Wu; Yanyan Zhang; Yang Li; Yuying Wu; Cheng Cheng; Dongsheng Hu; Liang Sun
Journal:  J Hum Hypertens       Date:  2021-05-12       Impact factor: 3.012

5.  Additive interaction between potentially modifiable risk factors and ethnicity among individuals in the Han, Tujia and Miao populations with first-ever ischaemic stroke.

Authors:  Na Zhang; Xinrui Wu; Mengyuan Tian; Xiaolei Wang; Jian Ding; Yong Tian; Chengcai Liang; Zhi Zeng; Hua Xiang; Hongzhuan Tan
Journal:  BMC Public Health       Date:  2021-06-03       Impact factor: 3.295

6.  Association between C reactive protein and all-cause mortality in the ELSA-Brasil cohort.

Authors:  Chams B Maluf; Sandhi Maria Barreto; Luana Giatti; Antonio Luiz Ribeiro; Pedro G Vidigal; Douglas R M Azevedo; Rosane H Griep; Sheila Maria Alvim Matos; Chen Ji; Francesco P Cappuccio; Michelle A Miller
Journal:  J Epidemiol Community Health       Date:  2020-02-26       Impact factor: 3.710

7.  The association between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study.

Authors:  Wen Wei; Hui Liu; Xiuping Qiu; Jushun Zhang; Jianqing Huang; Hangju Chen; Shuilin Qiu; Ruiyu Lin; Shihai Li; Mei Tu
Journal:  Diabetol Metab Syndr       Date:  2022-02-08       Impact factor: 3.320

Review 8.  The Harm of Metabolically Healthy Obese and the Effect of Exercise on Their Health Promotion.

Authors:  Liqiang Su; Yihe Pan; Haichun Chen
Journal:  Front Physiol       Date:  2022-07-14       Impact factor: 4.755

9.  Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China.

Authors:  Yunxing Jiang; Xianghui Zhang; Rulin Ma; Xinping Wang; Jiaming Liu; Mulatibieke Keerman; Yizhong Yan; Jiaolong Ma; Yanpeng Song; Jingyu Zhang; Jia He; Shuxia Guo; Heng Guo
Journal:  Clin Epidemiol       Date:  2021-06-09       Impact factor: 4.790

10.  Sex differences in the association between self-rated health and high-sensitivity C-reactive protein levels in Koreans: a cross-sectional study using data from the Korea National Health and Nutrition Examination Survey.

Authors:  Se-Won Park; Seong-Sik Park; Eun-Jung Kim; Won-Suk Sung; In-Hyuk Ha; Boyoung Jung
Journal:  Health Qual Life Outcomes       Date:  2020-10-14       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.